Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Cases of COVID-19 in Teriflunomide-Treated Patients With MS: Pharmacovigilance Report (1525) — Céline Louapre (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Cases of COVID-19 in Teriflunomide-Treated Patients With MS: Pharmacovigilance Report (1525)
Shared by
Massimo Filippi
Cases of COVID-19 in Teriflunomide-Treated Patients With MS: Pharmacovigilance Report (1525)
Article
2021
en
Authors
+4 more
CL
Céline Louapre
JG
José Manuel García‐Domínguez
LM
Lucia Moiola
Abstract
1 min read
To report pharmacovigilance data from teriflunomide-treated patients with MS and infection with SARS-CoV-2, causative agent of COVID-19.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2023
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study
Vassiliki Spiliopoulou
,
Ioannis Ntanasis‐Stathopoulos
,
Panagiotis Malandrakis
,
Maria Gavriatopoulou
,
Foteini Theodorakakou
,
Despina Fotiou
,
Magdalini Migkou
,
Μαρία Ρούσσου
,
Evangelos Eleutherakis‐Papaiakovou
,
Efstathios Kastritis
,
Meletios A Dimopoulos
,
Evangelos Terpos
Article
2022
Accelerated biological aging in COVID-19 patients
Xue Cao
,
Wenjuan Li
,
Ting Wang
,
Dongzhi Ran
,
Verónica Dávalos
,
Laura Planas‐Serra
,
Aurora Pujol
,
Manel Esteller
,
Xiaolin Wang
,
Huichuan Yu
Preprint
2021
SARS-CoV-2 infects lung epithelial cells and induces senescence and an inflammatory response in patients with severe COVID-19
Konstantinos Evangelou
,
Dimitris Veroutis
,
Periklis Foukas
,
Koralia Paschalaki
,
Nefeli Lаgopati
,
Marios Dimitriou
,
Angelos Papaspyropoulos
,
Orsalia Hazapis
,
Aikaterini Polyzou
,
Sophia Havaki
,
Athanassios Kotsinas
,
Christos Kittas
,
Athanasios G. Tzioufas
,
Laurence de Leval
,
Demetris Vassilakos
,
Sotirios Tsiodras
,
Ioannis Karakasiliοtis
,
Peter J Barnes
,
Vassilis G. Gorgoulis
Article
2025
Estimates of SARS-CoV-2 Infections and Population Immunity After the COVID-19 Pandemic in Austria: Analysis of National Wastewater Data
Uwe Riedmann
,
Alena Chalupka
,
Lukáš Richter
,
Martin Sprenger
,
Wolfgang Rauch
,
Hannes Schenk
,
Robert Krause
,
Peter Willeit
,
Herbert Oberacher
,
Tracy Beth Høeg
,
John P A Ioannidis
,
Stefan Pilz
Letter
2023
UDCA treatment against COVID‐19: Do we have enough clinical evidence for drug repurposing?
Luisa Ojeda‐Fernández
,
Marta Baviera
,
Giulia Macaluso
,
Simone Schena
,
Mauro Tettamanti
,
Massimo Cartabia
,
Andreana Foresta
,
Pier Manuccio Manucci
,
Alessandro Nobili
,
Giuseppe Remuzzi
,
Maria Carla Roncaglioni
Discussion(0)
No comments yet. Be the first to comment.